Cargando…

The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant

BACKGROUND: Rapastinel (GLYX-13) is a NMDA receptor modulator with glycine-site partial agonist properties. It is a robust cognitive enhancer and shows rapid and long-lasting antidepressant properties in both animal models and in humans. METHODS: Rapastinel was derived from a monoclonal antibody, B6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moskal, Joseph R., Burgdorf, Jeffrey S., Stanton, Patric K., Kroes, Roger A., Disterhoft, John F., Burch, Ronald M., Khan, M. Amin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327451/ https://www.ncbi.nlm.nih.gov/pubmed/26997507 http://dx.doi.org/10.2174/1570159X14666160321122703

Ejemplares similares

Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects
por: Donello, John E, et al.
Publicado: (2018)

BDNF Release and Signaling are Required for the Antidepressant Actions of GLYX-13
por: Kato, Taro, et al.
Publicado: (2017)

Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
por: Vasilescu, Andrei-Nicolae, et al.
Publicado: (2017)

IGFBP2 Produces Rapid-Acting and Long-Lasting Effects in Rat Models of Posttraumatic Stress Disorder via a Novel Mechanism Associated with Structural Plasticity
por: Burgdorf, Jeffrey, et al.
Publicado: (2017)

ERK/mTOR signaling may underlying the antidepressant actions of rapastinel in mice
por: Shen, Mengxin, et al.
Publicado: (2022)

Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects
por: Burgdorf, Jeffrey S, et al.
Publicado: (2022)

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
por: Yang, Bangkun, et al.
Publicado: (2016)

Insulin-Like Growth Factor I Produces an Antidepressant-Like Effect and Elicits N-Methyl-D-Aspartate Receptor Independent Long-Term Potentiation of Synaptic Transmission in Medial Prefrontal Cortex and Hippocampus
por: Burgdorf, Jeffrey, et al.
Publicado: (2015)

PI3K/AKT/mTOR Signaling-Mediated Neuropeptide VGF in the Hippocampus of Mice Is Involved in the Rapid Onset Antidepressant-Like Effects of GLYX-13
por: Lu, Yang, et al.
Publicado: (2015)

“Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity”
por: Moskal, Joseph R.
Publicado: (2017)

GLYX-13 pretreatment ameliorates long-term isoflurane exposure-induced cognitive impairment in mice
por: Liu, Huan, et al.
Publicado: (2019)

A translational EEG-based approach to assess modulation of long-lasting NMDAR-dependent synaptic plasticity
por: Burgdorf, Jeffrey S., et al.
Publicado: (2019)

NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory
por: Khan, M Amin, et al.
Publicado: (2017)

Scale-Up Synthesis and Identification of GLYX-13, a NMDAR Glycine-Site Partial Agonist for the Treatment of Major Depressive Disorder
por: Li, Wenchao, et al.
Publicado: (2018)

GLYX-13 Ameliorates Schizophrenia-Like Phenotype Induced by MK-801 in Mice: Role of Hippocampal NR2B and DISC1
por: Zhou, Dongsheng, et al.
Publicado: (2018)

Commentary: GLYX-13 Ameliorates Schizophrenia-Like Phenotype Induced by MK-801 in Mice: Role of Hippocampal NR2B and DISC1
por: Xie, Yuanyi, et al.
Publicado: (2018)

A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance
por: Su, Shengfang, et al.
Publicado: (2021)

Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms
por: Thomas, Alexandra M., et al.
Publicado: (2017)

Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
por: Wohleb, Eric S., et al.
Publicado: (2017)

Rapid-acting antidepressants and the circadian clock
por: Sato, Shogo, et al.
Publicado: (2021)

Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
por: Hare, Brendan D., et al.
Publicado: (2017)

Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity
por: Burgdorf, Jeffrey, et al.
Publicado: (2017)

Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
por: Duman, Ronald S.
Publicado: (2018)

Neurobiology of rapid acting antidepressants: convergent effects on GluA1-synaptic function
por: Duman, Ronald S., et al.
Publicado: (2019)

A prefrontal cortex alpha/delta switch controls the transition from positive to negative affective states
por: Burgdorf, Jeffrey S., et al.
Publicado: (2023)

Clinical specificity profile for novel rapid acting antidepressant drugs
por: Scala, Mauro, et al.
Publicado: (2023)

Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects
por: Hare, Brendan D., et al.
Publicado: (2019)

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in Mice
por: Zheng, Chen, et al.
Publicado: (2017)

NMDAR activation regulates the daily rhythms of sleep and mood
por: Burgdorf, Jeffrey S, et al.
Publicado: (2019)

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013)

Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018)

Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome
por: Crosson, Lori Ann, et al.
Publicado: (2009)

l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug
por: Chiechio, Santina, et al.
Publicado: (2017)

Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity
por: Warner-Schmidt, Jennifer, et al.
Publicado: (2023)

Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants
por: Yavorsky, Christian, et al.
Publicado: (2023)

How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy
por: Andrade, Chittaranjan, et al.
Publicado: (2010)

Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes
por: Viana, G.S.B., et al.
Publicado: (2020)

Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina
por: Lau, Jennifer C.M., et al.
Publicado: (2013)

PS128. Ketamine R(-) and S(+) Pharmacological Actions; Together or Separate Rapid Acting Antidepressants
por: Domino, Edward F.
Publicado: (2016)

Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?
por: Herzog, David P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iqe5etqn9459f6alrqqo1cah6u